134 related articles for article (PubMed ID: 32980979)
1. Return on Investment of a Breast Cancer Screening Program in Tanzania: Opportunity for Patient and Public Education.
Heisler Z; Eastwood B; Mwaiselage J; Kahesa C; Msami K; Soliman AS
J Cancer Educ; 2022 Jun; 37(3):701-708. PubMed ID: 32980979
[TBL] [Abstract][Full Text] [Related]
2. Cost-Effectiveness of Screening and Treatment for Cervical Cancer in Tanzania: Implications for other Sub-Saharan African Countries.
Nelson S; Kim J; Wilson FA; Soliman AS; Ngoma T; Kahesa C; Mwaiselage J
Value Health Reg Issues; 2016 Sep; 10():1-6. PubMed ID: 27881270
[TBL] [Abstract][Full Text] [Related]
3. Downstaging of cervical cancer in Tanzania over a 16-year period.
Mattick LJ; Ochs-Balcom HM; Mwaiselage J; Kahesa C; Gard AC; Shalan F; Soliman AS
Cancer Causes Control; 2021 Apr; 32(4):401-407. PubMed ID: 33559768
[TBL] [Abstract][Full Text] [Related]
4. Return on Investment Analysis of Breast Cancer Screening and Downstaging in Egypt: Implications for Developing Countries.
Skrundevskiy AN; Omar OS; Kim J; Soliman AS; Korolchuk TA; Wilson FA
Value Health Reg Issues; 2018 Sep; 16():22-27. PubMed ID: 29626738
[TBL] [Abstract][Full Text] [Related]
5. Breast Cancer Screening in Low-Income Countries: A New Program for Downstaging Breast Cancer in Tanzania.
Cherlin DS; Mwaiselage J; Msami K; Heisler Z; Young H; Cui Q; Soliman AS
Biomed Res Int; 2022; 2022():9795534. PubMed ID: 35425839
[TBL] [Abstract][Full Text] [Related]
6. Educational Opportunities for Down-Staging Breast Cancer in Low-Income Countries: an Example from Tanzania.
Yang K; Msami K; Calixte R; Mwaiselage J; Dorn J; Soliman AS
J Cancer Educ; 2019 Dec; 34(6):1225-1230. PubMed ID: 31435911
[TBL] [Abstract][Full Text] [Related]
7. Most women diagnosed with cervical cancer by a visual screening program in Tanzania completed treatment: evidence from a retrospective cohort study.
Gard AC; Soliman AS; Ngoma T; Mwaiselage J; Kahesa C; Chamberlain RM; Harlow SD
BMC Public Health; 2014 Sep; 14():910. PubMed ID: 25187329
[TBL] [Abstract][Full Text] [Related]
8. Needs for Professional Education to Optimize Cervical Cancer Screenings in Low-Income Countries: a Case Study from Tanzania.
Lavelle AE; Su D; Kahesa C; Soliman AS
J Cancer Educ; 2019 Feb; 34(1):124-129. PubMed ID: 28895070
[TBL] [Abstract][Full Text] [Related]
9. Developing Research Education Groups in African Cancer Centers: The Experience in Tanzania.
Msami K; Mbwana M; Mwaiselage J; Nyagabona S; Makani J; Dharsee N; Kahesa C; Soliman AS
J Cancer Educ; 2021 Jul; 36(Suppl 1):101-108. PubMed ID: 34128212
[TBL] [Abstract][Full Text] [Related]
10. Characteristics and geographic distribution of HIV-positive women diagnosed with cervical cancer in Dar es Salaam, Tanzania.
Lovgren K; Soliman AS; Ngoma T; Kahesa C; Meza J
Int J STD AIDS; 2016 Oct; 27(12):1049-1056. PubMed ID: 26464500
[TBL] [Abstract][Full Text] [Related]
11. Evidence for the need of educational programs for cervical screening in rural Tanzania.
Peters LM; Soliman AS; Bukori P; Mkuchu J; Ngoma T
J Cancer Educ; 2010 Jun; 25(2):153-9. PubMed ID: 20204578
[TBL] [Abstract][Full Text] [Related]
12. Impact of Initiating Screening Programs on Referral and Management of Cervical Cancer in Tanzania.
Sedani A; Soliman AS; Msami K; Msemo D; Mwaiselage J; Schmid K; Kahesa C
J Glob Oncol; 2019 Jul; 5():JGO1800052. PubMed ID: 31343933
[TBL] [Abstract][Full Text] [Related]
13. Early detection of breast cancer in countries with limited resources.
Anderson BO; Braun S; Lim S; Smith RA; Taplin S; Thomas DB;
Breast J; 2003; 9 Suppl 2():S51-9. PubMed ID: 12713497
[TBL] [Abstract][Full Text] [Related]
14. Quantifying the under-estimation of cervical Cancer in remote regions of Tanzania.
Gesink MP; Chamberlain RM; Mwaiselage J; Kahesa C; Jackson K; Mueller W; Meza JL; Soliman AS
BMC Cancer; 2020 Sep; 20(1):939. PubMed ID: 32998702
[TBL] [Abstract][Full Text] [Related]
15. A 10-Year Evaluation of New Jersey's National Breast and Cervical Cancer Early Detection Program: Comparison of Stage at Diagnosis in Enrollees and Nonenrollees.
Jerome-D'Emilia B; Suplee P; Kushary D
J Womens Health (Larchmt); 2020 Feb; 29(2):230-236. PubMed ID: 31436495
[No Abstract] [Full Text] [Related]
16. The National Cancer Screening Program for breast cancer in the Republic of Korea: is it cost-effective?
Kang MH; Park EC; Choi KS; Suh M; Jun JK; Cho E
Asian Pac J Cancer Prev; 2013; 14(3):2059-65. PubMed ID: 23679319
[TBL] [Abstract][Full Text] [Related]
17. Availability and affordability of anticancer medicines at the Ocean Road Cancer Institute in Dar es Salaam, Tanzania.
Yohana E; Kamuhabwa A; Mujinja P
East Afr J Public Health; 2011 Mar; 8(1):52-7. PubMed ID: 22066285
[TBL] [Abstract][Full Text] [Related]
18. Reason for late-stage breast cancer: absence of screening or detection, or breakdown in follow-up?
Taplin SH; Ichikawa L; Yood MU; Manos MM; Geiger AM; Weinmann S; Gilbert J; Mouchawar J; Leyden WA; Altaras R; Beverly RK; Casso D; Westbrook EO; Bischoff K; Zapka JG; Barlow WE
J Natl Cancer Inst; 2004 Oct; 96(20):1518-27. PubMed ID: 15494602
[TBL] [Abstract][Full Text] [Related]
19. Transforming breast cancer control campaigns in low and middle-income settings: Tanzanian experience with 'Check It, Beat It'.
Kassam D; Berry NS; Dharsee J
Glob Public Health; 2017 Feb; 12(2):156-169. PubMed ID: 27080412
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
